the relatively low levels of radiolabel in extra-hepatic tissues observed after oral dosing , together with the prolonged retention in this region of the liver , is consistent with the hepatotropic effects ( i.e . hepatic peroxisome proliferation and development of liver tumors ) exerted by this compound .
C0736268
hepatic tissues
C0023884
liver